Status:
RECRUITING
NOACs Use in AF or VTE (SUNSHINE Registry)
Lead Sponsor:
Henan Provincial People's Hospital
Conditions:
Atrial Fibrillation
Venous Thromboembolism
Eligibility:
All Genders
Brief Summary
The outcomes regiStry for non-vitamin k antagonist oral anticoagUlants treatmeNt in variouS tHrombotIc dIseases for better cliNical practicE (SUNSHINE) is a multicenter, prospective, observational non...
Detailed Description
The SUNSHINE registry will generate the extensive integrated repository of routine clinical care data for NOACs use in patients for various clinical scenarios (mainly with AF or VTE). It will provide ...
Eligibility Criteria
Inclusion
- Patients with clinically diagnosed with AF (eg, by electrocardiogram, Holter monitoring, implanted device, etc) or VTE (initial or recurrent acute VTE)
- Patients who use OACs therapy (including NOAC or VKA) within the preceding 3 months
- Patients can be enrolled from both inpatient or outpatient settings
Exclusion
- AF resulting from reversible cause factors (e.g., thyroid disease, postoperative AF)
- Patients with a diagnosis of valvular AF (valvular AF mainly refers to patients with AF that have either rheumatic valvular disease \[predominantly mitral stenosis\] or mechanical heart valves)
- Patients participating in an ongoing clinical trial in AF or VTE
- Have Multiple anticoagulation indications apart from AF or VTE
- Patients with incomplete information (illogical data, missing or insufficient data)
Key Trial Info
Start Date :
June 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05378308
Start Date
June 6 2022
End Date
May 31 2027
Last Update
June 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henan Provincial People's Hospital
Zhengzhou, Henan, China, 450000